medigraphic.com
SPANISH

Archivos de Medicina de Urgencia de México

ISSN 2594-3006 (Electronic)
ISSN 2007-1752 (Print)
Archivos de Medicina de Urgencia de México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 2

<< Back Next >>

Arch Med Urg Mex 2010; 2 (2)

Prevalence of risk factors for disease venous thrombotic patients hospitalized in Emergency Department

Aguilar DÓ, Russi HM, Rivera GML
Full text How to cite this article

Language: Spanish
References: 9
Page: 68-73
PDF size: 172.07 Kb.


Key words:

Venous thromboembolic disease (VTE), prevalence, risk factors.

ABSTRACT

Introduction: Venous thromboembolic is a multifactorial disease characterized by obstruction of venous secondary light. The prevalence of patients with risk is 52% in hospitalized patients. Risk factors for thrombotic disease include obesity, congestive heart failure, where there is venous stasis as a pro-coagulant and sepsis, among others. Objective: To determine the prevalence of risk factors for thrombotic disease in patients admitted to the observation room of the Emergency Department of the CMN «La Raza». Methods: During three months survey is applied to identify risk factors for thrombotic disease and determine its stratification. In patients older than 16 years with medical or surgical pathology. Results: 56% female and 44% male. Average age of 60 years (SD ± 19.2). The prevalence of risk factors for VTE is 85% with a 95% (83 ± 89.14). 32% for VTE thromboprophylaxis. The most common risk factor is age 60 to 74 years (18.2%). Conclusions: The prevalence of risk factors in our population is very high and the use of prophylaxis is not proportional to its presentation. The level of high risk to develop venous thrombotic disease is prevalent in our population.


REFERENCES

  1. Martínez M, Castañón G. Enfermedad tromboembólica venosa en la Unidad de Cuidados Intensivos. Rev Med IMSS 2002; 40(3): 233-245.

  2. Cohen AT, Tapson VF, Bergmanm JF, Goldhaber SZ, Kakkar AK, Deslander B et al. ENDORSE Investigators. Venous Thromboembolism Risk and Prophylaxis in the Acute Hospital Care Setting. (ENDORSE Stude): a multinational cros-sectional study. Journal Article multicenter study randomized controlled Trial. Research Support, Non-US.Got. Lancet 2008; 331 (9610); 387-94.

  3. Aaron B, Holley, Lisa K. Moores et al. Provider preferences for DVT prophylaxis, thrombosis research (2006) 117, 563-68.

  4. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. JAMA 1990; 263: 2753-2759.

  5. Caprini JA, Arcelus JI et al. State of the art venous thromboembolism prophylaxis. Scope 2001; 8: 228-240.

  6. Cade JF. High risk of the critically ill for VTE. Crit Care Med 1982; 10: 448-50.

  7. Geerts WH, Pineo GF, Heit JA, Bergquist D, Lassen MR, Colwell CW et al. Prevention of venous thromboembolism. Chest 2004; 126: 338S–400S.

  8. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339: 93-104.

  9. Baker WF Jr. Diagnosis of deep venous thrombosis and pulmonary embolism. Med Clin of North Am 1998; 82: 459-476.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Urg Mex. 2010;2